AMAG

AMAG Pharmaceuticals, Inc. News Headlines

$17.88
*  
0.13
 negative 
0.73%
Get AMAG Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

AMAG Pharma To Present At Needham Conference; Webcast At 2:20 PM ET
4/9/2014 1:20:00 PM - RTT News

Keryx Biopharma Names Greg Madison EVP And COO
2/10/2014 9:46:00 AM - RTT News

Wider-than-Expected Q4 Loss at AMAG - Analyst Blog
2/7/2014 11:40:01 AM - Zacks.com

AMAG Slides on Regulatory Setback - Analyst Blog
1/23/2014 7:40:01 PM - Zacks.com

AMAG Pharma. Gets Complete Response Letter From FDA For Feraheme - Quick Facts
1/22/2014 8:24:00 AM - RTT News

AMAG's Feraheme Revs Look Good - Analyst Blog
1/14/2014 6:20:01 PM - Zacks.com

Update on AMAG's Feraheme - Analyst Blog
1/9/2014 2:00:01 PM - Zacks.com

MYGN Unveils Prolaris Study Results - Analyst Blog
12/5/2013 5:05:32 PM - Zacks.com

Oculus Gains on Scar Product Approval - Analyst Blog
12/5/2013 5:04:54 PM - Zacks.com

BioMarin Seeks Canadian Approval - Analyst Blog
12/5/2013 12:50:01 PM - Zacks.com

Positive Data on ChemoCentryx Candidate - Analyst Blog
12/5/2013 12:05:33 PM - Zacks.com

AMBI Plunges on Disappointing FDA News - Analyst Blog
12/5/2013 12:05:21 PM - Zacks.com

Cytokinetics Progresses with Tirasemtiv - Analyst Blog
12/5/2013 8:06:01 AM - Zacks.com

Affymetrix Remains Outperform - Analyst Blog
12/4/2013 3:40:01 PM - Zacks.com

MYGN Battles Odds, Shares Fall - Analyst Blog
12/4/2013 2:05:07 PM - Zacks.com

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
12/4/2013 9:53:53 AM - Zacks.com

FDA Agrees to BDSI's Phase III Program - Analyst Blog
12/3/2013 11:53:56 AM - Zacks.com

Orphan Drug Status for CNAT's Emricasan - Analyst Blog
12/3/2013 11:53:34 AM - Zacks.com

Merrimack Pharmaceuticals (MACK) Jumps: Stock Rises 6.6% - Tale of the Tape
12/3/2013 9:54:47 AM - Zacks.com

XOMA Corporation (XOMA) Worth Watching: Stock Surges 22.2% - Tale of the Tape
12/3/2013 9:44:01 AM - Zacks.com

Aeterna Zentaris Closes Public Offering - Analyst Blog
12/2/2013 5:53:39 PM - Zacks.com

Bayer Hits 52-Week High - Analyst Blog
12/2/2013 5:30:01 PM - Zacks.com

MiMedx Group (MDXG) in Focus: Stock Moves Up 5.9% - Tale of the Tape
12/2/2013 9:57:01 AM - Zacks.com

Oncothyreon Inc. (ONTY) in Focus: Stock Up 5.2% - Tale of the Tape
12/2/2013 9:44:01 AM - Zacks.com

AMAG Raised to Strong Buy - Analyst Blog
11/29/2013 1:00:01 PM - Zacks.com